EU device directive recast could save money for innovative businesses, says Minor
This article was originally published in Clinica
Executive Summary
The European Commission hopes that the recast of the medical device directives, the first draft of which it plans to propose in April next year, will enable innovative medtech businesses to save money on administrative costs and plough these savings back into research and development to bring further innovation.